Samsung Biologics
207940.KS
#478
Rank
NZ$89.46 B
Marketcap
NZ$1,844
Share price
-1.45%
Change (1 day)
24.95%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2026 (TTM): NZ$2.91 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are NZ$3.08 Billion. In 2025 the company made an earning of NZ$2.73 Billion, an increase over its 2024 earnings that were of NZ$1.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$2.91 B6.37%
2025 NZ$2.73 B45.86%
2024 NZ$1.87 B12.54%
2023 NZ$1.66 B9.73%
2022 NZ$1.52 B67.4%
2021 NZ$0.90 B104%
2020 NZ$0.44 B57.54%
2019 NZ$0.28 B-45.41%
2018 NZ$0.51 B-389.75%
2017 -NZ$0.18 Billion-46.69%
2016 -NZ$0.34 Billion